• Overview
    Overview
  • Revenue
    Revenue
  • Segments
    • Revenue by Product
    • Revenue by Region
    Segments
  • Financials
    • Income Statement
    • Balance Sheet
    • Cashflow Statements
    • Profitability
    • Ratios
    Financials
  • People
    • CEO Salary
    • Employees
    • Revenue per Employee
    • Net Income per Employee
    People
  • OwnershipOwnership
    Ownership
  • Competitors
    Competitors
  • Stocks
    • Market Cap
    • PE Ratio
    • Dividend
    Stocks
  • News
    • Company News
    • Press Releases
    News
  • Earnings Calls
    Earnings Calls
  • Documents
    • Annual Reports
    • Quarterly Reports
    • SEC Filings
    Documents
Submit Feedback
Submit Feedback (Sign in required)
Bullfincher logo
Recent searches
    Trending searches
    • Company logo Caterpillar Overview
    • Company logo Apple Revenue
    • Company logo NVIDIA Corporation Employees
    • Home
    • Companies
    • Calendars
    • Ranking
    • Blog
    • Login

    Submit feedback to Bullfincher

    REGN logo Regeneron Pharmaceuticals +
    REGN logo
    Regeneron Pharmaceuticals
    +
    • Overview
    • Revenue
    • Segments
      • Revenue by Product
      • Revenue by Region
    • Financials
      • Income Statement
      • Balance Sheet
      • Cashflow Statement
      • Profitability
      • Ratios
    • People
      • CEO Salary
      • Employees
      • Revenue per Employee
      • Net Income per Employee
    • Ownership
    • Competitors
    • Stocks
      • Market Cap
      • PE Ratio
      • Dividend
    • News
      • Company News
      • Press Releases
    • Earnings Calls
    • Documents
      • Annual Report 10K
      • Quarterly Report 10Q
      • SEC Filings
    REGN logo Regeneron Pharmaceuticals REGN + Follow
    • Revenue
    • Employees
    • Market Capitalization
    CEO Salary Employees Revenue per Employee Net Income per Employee

    Regeneron Pharmaceuticals Revenue per Employee (2016-2025)

    • In fiscal year 2025, the revenue per employee at Regeneron Pharmaceuticals was $930.75 K. The revenue per employee decreased by $9.40 K from $940.16 K (in 2024) to $930.75 K (in 2025). It represents a -1.00% year-over-year decline in revenue per employee.

    • Over the past 10 years (2016-2025):
    • The Highest revenue per employee at Regeneron Pharmaceuticals was $1.55 M in fiscal year 2021.
    • The Lowest revenue per employee was $809.58 K in fiscal year 2019.
    • The Average revenue per employee was $991.85 K.

    • Learn more about Regeneron Pharmaceuticals's Revenue by Segment and Revenue by Region.

      Check out competitors to Regeneron Pharmaceuticals in a side-by-side comparison.

      Explore additional financial metrics for Regeneron Pharmaceuticals.


      Definition of Revenue per Employee :
    • Revenue per Employee measures the amount of money a business makes through one employee. Refer to our glossary for more details, examples, and formulas.
    Continue reading...

    Regeneron Pharmaceuticals's Revenue per Employee Trend

    2015 954355.34883721
    2016 900079.07407407
    2017 947133.38709677
    2018 906864.86486486
    2019 809580.24691358
    2020 931393.1820673
    2021 1550125.3858025
    2022 1027162.2647878
    2023 975256.50557621
    2024 940156.22931286
    2025 930752.75794938

    2025

    Regeneron Pharmaceuticals's revenue per employee was $930.75 K in fiscal year 2025.

    2024

    Regeneron Pharmaceuticals's revenue per employee was $940.16 K in fiscal year 2024.

    2023

    Regeneron Pharmaceuticals's revenue per employee was $975.26 K in fiscal year 2023.

    2022

    Regeneron Pharmaceuticals's revenue per employee was $1.03 M in fiscal year 2022.

    2021

    Regeneron Pharmaceuticals's revenue per employee was $1.55 M in fiscal year 2021.

    2020

    Regeneron Pharmaceuticals's revenue per employee was $931.39 K in fiscal year 2020.

    2019

    Regeneron Pharmaceuticals's revenue per employee was $809.58 K in fiscal year 2019.

    2018

    Regeneron Pharmaceuticals's revenue per employee was $906.86 K in fiscal year 2018.

    2017

    Regeneron Pharmaceuticals's revenue per employee was $947.13 K in fiscal year 2017.

    2016

    Regeneron Pharmaceuticals's revenue per employee was $900.08 K in fiscal year 2016.

    Continue reading...

    Regeneron Pharmaceuticals's Revenue Per Employee (Year-over-Year Change)

    2016 -5.69
    2017 5.23
    2018 -4.25
    2019 -10.73
    2020 15.05
    2021 66.43
    2022 -33.74
    2023 -5.05
    2024 -3.6
    2025 -1

    2025

    Regeneron Pharmaceuticals's revenue per employee decreased -1% during fiscal year 2025 compared to 2024.
    This represents a decline of -$9.40 K from $940.16 K (in 2024) to $930.75 K (in 2025).

    2024

    Regeneron Pharmaceuticals's revenue per employee decreased -3.6% during fiscal year 2024 compared to 2023.
    This represents a decline of -$35.10 K from $975.26 K (in 2023) to $940.16 K (in 2024).

    2023

    Regeneron Pharmaceuticals's revenue per employee decreased -5.05% during fiscal year 2023 compared to 2022.
    This represents a decline of -$51.91 K from $1.03 M (in 2022) to $975.26 K (in 2023).

    2022

    Regeneron Pharmaceuticals's revenue per employee decreased -33.74% during fiscal year 2022 compared to 2021.
    This represents a decline of -$522.96 K from $1.55 M (in 2021) to $1.03 M (in 2022).

    2021

    Regeneron Pharmaceuticals's revenue per employee increased 66.43% during fiscal year 2021 compared to 2020.
    This represents an increase of $618.73 K from $931.39 K (in 2020) to $1.55 M (in 2021).

    2020

    Regeneron Pharmaceuticals's revenue per employee increased 15.05% during fiscal year 2020 compared to 2019.
    This represents an increase of $121.81 K from $809.58 K (in 2019) to $931.39 K (in 2020).

    2019

    Regeneron Pharmaceuticals's revenue per employee decreased -10.73% during fiscal year 2019 compared to 2018.
    This represents a decline of -$97.28 K from $906.86 K (in 2018) to $809.58 K (in 2019).

    2018

    Regeneron Pharmaceuticals's revenue per employee decreased -4.25% during fiscal year 2018 compared to 2017.
    This represents a decline of -$40.27 K from $947.13 K (in 2017) to $906.86 K (in 2018).

    2017

    Regeneron Pharmaceuticals's revenue per employee increased 5.23% during fiscal year 2017 compared to 2016.
    This represents an increase of $47.05 K from $900.08 K (in 2016) to $947.13 K (in 2017).

    2016

    Regeneron Pharmaceuticals's revenue per employee decreased -5.69% during fiscal year 2016 compared to -.
    This represents a decline of -$54.28 K from $954.36 K (in 2015) to $900.08 K (in 2016).

    Continue reading...

    Regeneron Pharmaceuticals Revenue per Employee History

    Sign in to download table

    Period Revenue per Employee Year-over-Year Change
    2025 $930.75 K -$9.40 K 1%
    2024 $940.16 K -$35.10 K 3.6%
    2023 $975.26 K -$51.91 K 5.05%
    2022 $1.03 M -$522.96 K 33.74%
    2021 $1.55 M $618.73 K 66.43%
    2020 $931.39 K $121.81 K 15.05%
    2019 $809.58 K -$97.28 K 10.73%
    2018 $906.86 K -$40.27 K 4.25%
    2017 $947.13 K $47.05 K 5.23%
    2016 $900.08 K -$54.28 K 5.69%

    Frequently Asked Questions

    What is Regeneron Pharmaceuticals's revenue per employee?

    In the fiscal year 2025, Regeneron Pharmaceuticals's revenue per employee was $930.75 K.

    What is the annual change in Regeneron Pharmaceuticals's revenue per employee?

    Regeneron Pharmaceuticals's revenue per employee decreased by -1% in 2025 compared to 2024.

    Related

    • A logo Agilent Technologies Revenue per Employee
    • LLY logo Eli Lilly and Company Revenue per Employee
    • SYK logo Stryker Corporation Revenue per Employee
    • JNJ logo Johnson & Johnson Revenue per Employee
    • ABBV logo AbbVie Revenue per Employee
    • MRK logo Merck & Co. Revenue per Employee
    • TMO logo Thermo Fisher Scientific Revenue per Employee
    • ABT logo Abbott Laboratories Revenue per Employee
    • DHR logo Danaher Corporation Revenue per Employee

    People Also Search For

    • CAT logo Caterpillar
    • AAPL logo Apple
    • NVDA logo NVIDIA Corporation
    • MSFT logo Microsoft Corporation
    • AMZN logo Amazon.com
    • TSLA logo Tesla
    • GOOGL logo Alphabet (Google)
    • NKE logo NIKE
    • WMT logo Walmart
    • META logo Meta Platforms (Facebook)
    • PEP logo PepsiCo
    • TGT logo Target Corporation
    footer logo

    Bullfincher is a “visual-first” business intelligence and research platform. We believe that behind every great company, there is a great story. At Bullfincher, we make story-telling a little easier using dynamic visuals, charts, and graphs.

    explore
    • About Us
    • Blog
    • FAQ
    • Glossary
    Discover
    • Privacy Policy
    • Contact us
    • Submit Feedback
    • Advertise with Us
    Subscribe to our Newsletter !

    Don’t worry, we won’t spam you.

    Disclaimers - All data and information is provided “as is” for informational purposes only and is not intended for trading purposes or financial, investment, tax, legal, accounting, or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. Bullfincher is not an investment adviser, financial adviser, or a securities broker.None of the data and information constitutes investment advice nor an offering, recommendation, or solicitation by Bullfincher to buy, sell, or hold any security or financial product, and Bullfincher makes no representation (and has no opinion) regarding the advisability or suitability of any investment.

    None of the data and information constitutes investment advice (whether general or customized). The financial products or operations referred to in such data and information may not be suitable for your investment profile and investment objectives or expectations. It is your responsibility to consider whether any financial product or operation is suitable foryou based on your interests, investment objectives, investment horizon, and risk appetite. Bullfincher shall not be liable for any damages arising from any operations or investments in financial products referred to within. Bullfincher does not recommend using the data and information provided as the only basis for making any investment decision.

    Bullfincher 2026, All rights reserved

    Submit feedback to Bullfincher

    Submit your feedback


    Note: Please upload only jpg and png file and size 5 MB allowed.